Skip to content
LATEST
Health

Peter Attia revises longevity views after 400 podcast episodes

The Oct. 12 AMA episode covers changed positions on fasting, keto, metformin, rapamycin, cancer screening and exercise, with full access for subscribers.

Peter Attia revises longevity views after 400 podcast episodes

Peter Attia used the Oct. 12 AMA #90 episode of The Peter Attia Drive to revisit 400 episodes over eight years, saying his views on fasting, keto, metformin, rapamycin, screening and exercise have changed.

Evidence grade: Claim (no study cited). The episode matters for readers following longevity medicine because it covers nutrition, drugs, cancer screening and training approaches that Attia has discussed across the podcast’s run.

Attia, host of The Peter Attia Drive, framed the episode as a review of earlier positions. “I've been around many really, really great scientists. And one of the characteristics they all have in common is they're not married to a particular thesis being right.

They're married to getting things as right as possible and reducing uncertainty by following the data wherever those data take them,” he said on the podcast published Oct. 12.

The nutrition section, according to the show notes, covers Attia’s changed thinking on ketogenic diets, prolonged fasting and the relationship among dietary restriction, time restriction and calorie restriction. The page says he also discusses why GLP-1 agonists, drugs in a class used to affect appetite and glucose pathways, are shifting attention toward calorie restriction.

On drugs often discussed in longevity circles, the summary says Attia no longer views metformin as geroprotective for metabolically healthy people. Geroprotective means intended to protect against ageing-related biological decline. The same episode covers his increasing uncertainty about rapamycin, while noting that animal data remain part of the case for studying it.

The cancer-screening discussion includes whole-body magnetic resonance imaging, or MRI, and blood-based cancer tests often called liquid biopsies. The show notes say Attia discusses declining quality in whole-body MRI, more targeted alternatives, the NHS-Galleri trial and why detecting early-stage disease is more relevant than finding late-stage cancer.

Attia also revisits exercise programming. The page says he has become less rigid about the 80/20 Zone 2 framework, an endurance-training approach that puts most work at lower intensity. The episode also covers lower-volume training for people with limited time and his move away from heavy barbell squats and deadlifts in favor of risk management.

For readers, the main implication is not that any one fasting, drug, imaging or exercise choice has been proved or disproved by this episode. The documented development is that a longevity-medicine podcaster is placing more emphasis on durable habits and less on marginal optimization across nutrition, pharmacology, cancer screening and training.

Non-subscribers listening in a podcast player can hear only a preview. Subscribers can access the full AMA through a private RSS feed or the episode page.

Source: Podcast show-notes page, The Peter Attia Drive, Oct. 12, 2026.

Atlas360 reports health research and does not provide medical advice.

More stories

Latest news